Citation Impact
Citing Papers
Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification
1999 Standout
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
2007 Standout
Delayed gastric emptying (DGE) after pancreatic surgery: A suggested definition by the International Study Group of Pancreatic Surgery (ISGPS)
2007 Standout
Healing and relapse of severe peptic esophagitis after treatment with omeprazole
1988
The role of tumour‐associated macrophages in tumour progression: implications for new anticancer therapies
2002 Standout
Immunolocalization of urokinase‐type plasminogen activator in adenomas and carcinomas of the colorectum
1991
Expression of plasminogen activator inhibitor type 1 by human prostate carcinoma cells inhibits primary tumor growth, tumor-associated angiogenesis, and metastasis to lung and liver in an athymic mouse model.
1995
Review article: the role of butyrate on colonic function
2007 Standout
Gastroduodenal Crohn's Disease: Medical Management
2003
Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?
1998 Standout
Endothelial and macrophage upregulation of urokinase receptor expression in human renal cell carcinoma
1997
European evidence based consensus for endoscopy in inflammatory bowel disease
2013 Standout
Autoantibody testing in children with newly diagnosed type 1 diabetes mellitus
2004
The Otolaryngologic Manifestations of Gastroesophageal Reflux Disease (GERD): A Clinical Investigation of 225 Patients Using Ambulatory 24‐Hour pH Monitoring and an Experimental Investigation of the Role of Acid and Pepsin in the Development of Laryngeal Injury
1991 Standout
Stimulation of Plasminogen Activator Inhibitor-1 Expression in Immortalized Human Trophoblast Cells Cultured under Low Levels of Oxygen
1998
The natural history of corticosteroid therapy for inflammatory bowel disease: A population-based study
2001 Standout
Omeprazole or Ranitidine in the Treatment of Reflux Esophagitis: Results of a Double-Blind, Randomized, Scandinavian Multicenter Study
1988
Proximal Crohn's Disease: Review of the Clinicopathologic Features and Therapy
2001
Omeprazole (40 mg) is superior to ranitidine in short-term treatment of ulcerative reflux esophagitis
1988
Prognostic value of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitors PAI-1 and PAI-2 in breast carcinomas
1994
The urokinase-type plasminogen activator system in cancer metastasis: A review
1997 Standout
The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo
2012 Standout
Crohnʼs Jejunoileitis: The Pediatricianʼs Perspective on Diagnosis and Management
2005
A Novel Placement Method of the Bravo Wireless pH Monitoring Capsule for Measuring Intragastric pH
2008
Wireless capsule endoscopy and proximal small bowel lesions in Crohn’s disease
2010
Meta-Analysis of the Effect of Placebo on the Outcome of Medically Treated Reflux Esophagitis
1995
Bradykinin and nitric oxide in infectious disease and cancer
1996
Cellular markers that distinguish the phases of hemangioma during infancy and childhood.
1994 Standout
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
2010 Standout
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
2013 Standout
Management of Crohn's Disease in Adults
2009 Standout
Gastric emptying following pylorus-preserving whipple and duodenum-preserving pancreatic head resection in patients with chronic pancreatitis
1997
Circadian clock disruption improves the efficacy of chemotherapy through p73-mediated apoptosis
2011 StandoutNobel
Regulation of the endothelial cell urokinase-type plasminogen activator receptor. Evidence for cyclic AMP-dependent and protein kinase C-dependent pathways.
1993 StandoutNobel
Functional characteristics of receptor-bound urokinase on human monocytes: catalytic efficiency and susceptibility to inactivation by plasminogen activator inhibitors
1989
DOUBLE-BLIND MULTICENTRE COMPARISON OF OMEPRAZOLE AND RANITIDINE IN THE TREATMENT OF REFLUX OESOPHAGITIS
1987
Examination of urokinase protein/transcript levels and their relationship with laminin degradation in cultured colon carcinoma.
1989
THE ANTHROPOLOGY OF PHARMACEUTICALS: A Biographical Approach
1996 Standout
Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee
2010 StandoutNobel
Prognostic relevance of plasminogen activators and their inhibitors in colorectal cancer.
1994
Interaction of single-chain urokinase-type plasminogen activator with human endothelial cells.
1990 StandoutNobel
Targeting Signal Transduction Pathways in Colorectal Cancer—More Than Skin Deep
2005
Overexpression of urokinase receptor increases matrix invasion without altering cell migration in a human osteosarcoma cell line.
1993 StandoutNobel
PERSPECTIVES OF THE PLACEBO PHENOMENON: General Medical Effectiveness and Human Biology: Placebo Effects in the Treatment of Ulcer Disease
1983
The effect of antisense inhibition of urokinase receptor in human squamous cell carcinoma on malignancy.
1994
Plasmin/Plasminogen System in Colorectal Cancer
2002
Localization of urokinase-type plasminogen activator in stromal cells in adenocarcinomas of the colon in humans.
1991
Expression of hypoxia-inducible factor 1? in brain tumors
2000 StandoutNobel
Engineering of Kuma030: A Gliadin Peptidase That Rapidly Degrades Immunogenic Gliadin Peptides in Gastric Conditions
2015 StandoutNobel
Works of Lamers Cb being referenced
Increased urokinase receptor levels in human gastrointestinal neoplasia and related liver metastases.
1993
Serum pancreatic polypeptide responses to food and secretion in patients with Billroth I and Billroth II gastrectomies and in normal subjects.
1982
Cimetidine in the treatment of severe ulcerative reflux oesophagitis; results of an 8-week double-blind study and of subsequent long-term maintenance treatment.
1980
Measurement of mucosa-specific antibodies against gliadin by a sensitive technique using the biotin-streptavidin system.
1987
[Suppression of gastric acid production using cimetidine; results of a double-blind study of the significance of cimetidine for the treatment of peptic ulcers].
1978
Plasminogen activators and tumor development in the human colon: activity levels in normal mucosa, adenomatous polyps, and adenocarcinomas.
1987
Clinical aspects of Crohn's disease of the upper gastrointestinal tract: a comparison with distal Crohn's disease.
1997
Glass and antimony electrodes for long-term pH monitoring: a dynamic in vitro comparison.
1995